DJ Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT.AU)$ slid 1.84% to $126.19 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.37% to 6,339.39 and Dow Jones Industrial Average falling 0.74% to 44,130.98.
The stock's fall snapped a two-day winning streak.
Abbott Laboratories closed 10.65% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.51% to $164.74, Pfizer Inc. $(PFE.AU)$ fell 2.18% to $23.29, and Merck & Co. Inc. $(MRK.UK)$ fell 4.44% to $78.12.
Trading volume (6.7 M) remained 80,714 below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 31, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.